Scientists Map Gut Drainage System to Reveal Hidden Health Biomarkers
New research identifies unique molecular signatures in gut lymph and blood that could transform digestive health monitoring.
20 articles
New research identifies unique molecular signatures in gut lymph and blood that could transform digestive health monitoring.
Advanced spatial mapping shows vascular regions drive cardiac aging through inflammation and senescence accumulation.
Researchers created the first comprehensive atlas of bone metastases, revealing new immune therapy combinations that could help patients.
Scientists discover cancer-specific RNA molecules in blood that could revolutionize early detection and monitoring.
A forward genetic screen in mice reveals HELZ2 helicase degrades APOB mRNA, linking RNA stability to fatty liver disease and heart disease risk.
A systematic review of 2,521 patients maps how genetic architecture shapes triglyceride severity, pancreatitis risk, and liver disease burden.
Scientists discover how a molecular switch in blood vessel cells accelerates aging and plaque formation, revealing new therapeutic targets.
Researchers mapped cancer surface proteins across 85 patient samples, identifying FAT2 as a promising target for CAR-T cell therapy.
New microfluidic device identifies early-stage cancers across multiple types with 91-100% accuracy using just four proteins from blood samples.
Study reveals how polygenic scores can predict and protect against inherited heart conditions, improving risk assessment.
New genetic approach could revolutionize how we develop heart medications, potentially saving billions in failed drug trials.
New research reveals how a key RNA processing protein helps immune cells mature properly to fight artery plaque buildup.
Revolutionary gene-editing technology CRISPR becomes available outside the US, offering new hope for treating genetic diseases worldwide.
New framework proposes treating interconnected organ diseases together rather than separately for better outcomes.
Scientists discover how an unusual gene fusion in melanoma still drives cancer growth and responds to targeted treatment.
New research reveals specific proteins that explain why lower socioeconomic status increases cardiovascular disease risk in older adults.
Cas13-based RNA editing shows promise for treating hereditary hypertrophic cardiomyopathy by correcting disease-causing mutations at the RNA level.
Scientists address concerns about sacituzumab govitecan therapy for aggressive triple-negative breast cancer cases.
A 2025 review maps the molecular drivers of cardiac aging and evaluates drugs, CRISPR, stem cells, and lifestyle as countermeasures.
Mendelian randomization links circulating inflammatory proteins to retinal microvascular changes, heart disease risk, and lifespan โ establishing causal direction.